Sarepta Therapeutics ROI - Return on Investment 2010-2024 | SRPT

Sarepta Therapeutics return on investment for the quarter ending September 30, 2024 was 5.64.

  • Sarepta Therapeutics average return on investment for 2023 was -41.69, a 38% decline from 2022.
  • Sarepta Therapeutics average return on investment for 2022 was -30.21, a 10.41% increase from 2021.
  • Sarepta Therapeutics average return on investment for 2021 was -33.72, a 5.17% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Sarepta Therapeutics ROI - Return on Investment 2010-2024 | SRPT

  • Sarepta Therapeutics average return on investment for 2023 was -41.69, a 38% decline from 2022.
  • Sarepta Therapeutics average return on investment for 2022 was -30.21, a 10.41% increase from 2021.
  • Sarepta Therapeutics average return on investment for 2021 was -33.72, a 5.17% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.